+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Subcutaneous immunization with purified herpes simplex virus glycoprotein d protects against keratitis and latency following corneal challenge with herpes simplex virus type 1



Subcutaneous immunization with purified herpes simplex virus glycoprotein d protects against keratitis and latency following corneal challenge with herpes simplex virus type 1



Investigative Ophthalmology & Visual Science 27(3 SUPPL): 114




(PDF emailed within 1 workday: $29.90)

Accession: 029242171

Download citation: RISBibTeXText


Related references

Subcutaneous immunization with uv inactivated herpes simplex virus protects against keratitis and latency following corneal herpes simplex virus type 1 challenge. Investigative Ophthalmology & Visual Science 27(3 SUPPL): 114, 1986

Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1. Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174, 1985

Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. Journal of General Virology 70: 2587-2594, 1989

DNA vaccine expressing herpes simplex virus 1 glycoprotein C and D protects mice against herpes simplex keratitis. International Journal of Ophthalmology 10(11): 1633-1639, 2017

Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis. Immunological Investigations 40(3): 265-278, 2011

Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations. Investigative Ophthalmology & Visual Science 38(6): 1213-1221, 1997

Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2. Frontiers in Microbiology 3: 158, 2012

Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis. Investigative Ophthalmology & Visual Science 34(8): 2460-2468, 1993

Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reaction. Acta Virologica 39(1): 37-49, 1995

Bilateral Herpes Simplex Virus-related Peripheral Ulcerative Keratitis Leading to Corneal Perforation in a Patient with Primary Herpes Simplex Virus Infection. Journal of Ophthalmic and Vision Research 14(1): 93-96, 2019

Synthesis of an antigenic determinant of the herpes simplex virus glycoprotein d that stimulates the induction of virus neutralizing antibodies and confers protection against a lethal challenge of herpes simplex virus. Chanock, R M And R A Lerner (Ed ) Modern Approaches to Vaccines: Molecular And Chemical Basis Of Virus Virulence And Immunogenicity; Symposium, Cold Spring Harbor, N Y , Sept 1983 Xxvii+457p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus 145-150, 1984

Physical mapping of herpes simplex virus coded functions and poly peptides by marker rescue and analysis of herpes simplex virus type 1 herpes simplex virus type 2 inter typic recombinants. De-The, G , W Henle And F Rapp (Ed ) Iarc (International Agency For Research on Cancer) Science Publications, No 24 Oncogenesis And Herpesviruses, Iii Part 1: Dna Of Herpesviruses, Viral Antigens, Cell-Virus Interaction; Proceedings Of The 3rd International Symposium, Cambridge, Mass , Usa, July 25-29, 1977 Lv+580p International Agency For Research on Cancer: Lyon, France Illus P11-32, 1978, 1979

Mapping of a herpes simplex virus type 2 encoded function that affects the susceptibility of herpes simplex virus infected target cells to lysis by herpes simplex virus specific cyto toxic t lymphocytes. Journal of Virology 49(3): 766-771, 1984

Investigation of the virulence genes of herpes simplex virus type 2 by experimental infection in vivo with defined intertypic recombinants of a virulent herpes simplex virus type 2x an avirulent herpes simplex virus type. Medical Microbiology & Immunology 174(5): 237-248, 1985

Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody. Infection and Immunity 40(1): 184-189, 1983